Marker Therapeutics, Inc.
MRKR· Nasdaq
MRKRMarker Therapeutics, Inc.
Filed Aug 18, 2014 · 10-Q · 49 days after period end · 0001424884-14-000092
| Metric | Q2 2014 | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Net Income | $753.48K | -$870.81K | -$2.54M | -$404.38K |
| EPS Diluted | $0.05 | -$0.87 | -$0.04 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marker Therapeutics, Inc. · CIK 1094038 · Engraved from SEC EDGAR
ended Jun 30, 2014 · filed Aug 18, 2014 · 49 d after period end
